Katherine Garman

The hybrid retreat showcased the latest gastric cancer, blood cancer, pediatric sarcoma, glioblastoma, breast cancer, and immune micro-environment research.

As Duke celebrates more than 50 years of cancer breakthroughs, a new research program works toward a future when no one ever develops cancer.

Learn about some notable BRPC/DCI cancer research collaborations and why the partnership is core to winning big grants for cancer research.

Here are some of the Duke Cancer Institute faculty, researchers, and clinical providers whose work has recently been featured by the media, academic trade publications & journals.

DCI director Michael B. Kastan, MD, PhD, announced a planned reconfiguration of DCI’s NCI-Designated Research Programs and welcomed new research leaders.

As the COVID-19 pandemic shines a light on health disparities, efforts to find new ways to reduce them get a boost.